Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Scinai Immunotherapeutics Ltd.

Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business Unit
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Tickers SCNI
Scinai Immunotherapeutics Provides Update Regarding Nasdaq Compliance
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Tickers SCNI
European Investment Bank (EIB) considering extending maturity of its financial facility contract with Scinai Immunotherapeutics in light of Scinai’s recent strategic pivot
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Tickers SCNI
Scinai Reports Third Quarter 2023 Financial Results and Provides Business Update
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Tickers SCNI
Scinai Immunotherapeutics to Attend BIO-Europe Munich 2023
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Tickers SCNI
Scinai Immunotherapeutics to Showcase its end-to-end cGMP Biologics CDMO Services at CPHI Barcelona 2023
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Tickers SCNI
Scinai Immunotherapeutics Announces Closing of $1.33 Million Registered Direct Offering
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Tickers SCNI
Scinai Immunotherapeutics Announces $1.33 Million Registered Direct Offering
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Tickers SCNI
Scinai Immunotherapeutics Innovative Plaque Psoriasis Treatment Shows Encouraging Preclinical Results
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Tickers SCNI
Scinai Immunotherapeutics Ltd. to participate this week in H.C. Wainwright 25th Annual Global Investment Conference in New York and LSX USA Congress 2023 in Boston
From Scinai Immunotherapeutics Ltd.
Via GlobeNewswire
Tickers SCNI
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.